Neonatal Outcome by Reason for Delivery

NCT ID: NCT01818518

Last Updated: 2019-06-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

995 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-31

Study Completion Date

2016-07-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the rate of Composite Neonatal Morbidity for very preterm babies delivered secondary to preterm labor (PTL) vs. prelabor rupture of membranes (PROM). Composite neonatal morbidity is defined as ≥ 1 of the following: Respiratory Distress Syndrome (RDS) (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood culture-proven sepsis, necrotizing enterocolitis (NEC), or perinatal death (stillbirth or death before neonatal hospital discharge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, observational study that will use information from the medical records of mothers and their newborns. This study seeks to determine the rate of Composite Neonatal Morbidity for very preterm babies delivered secondary to preterm labor (PTL) vs. prelabor rupture of membranes (PROM). Composite neonatal morbidity is defined as ≥ 1 of the following: Respiratory Distress Syndrome (RDS) (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood culture-proven sepsis, necrotizing enterocolitis (NEC), or perinatal death (stillbirth or death before neonatal hospital discharge.

Secondary Objectives: 1) Difference in mortality between the PTL and PROM groups, composite morbidity differences for other reasons for premature delivery, and individual morbidities including IVH, PVL, RDS, sepsis, seizures, BPD and NEC

Study Population: All babies from singleton pregnancies delivering in each of the involved hospitals who deliver at less than 32 weeks of gestation who are stillborn, who die in the delivery room and who are cared for in the Neonatal Intensive Care Unit (NICU) will be included.

Planned Sample Size: We plan a two year study and estimate based on historical data for the institutions to be included in the study, which should yield approximately 6000 babies less than (\<) 32w0d gestation. For a 10% difference in composite morbidity (assuming 90% power and two-sided alpha=0.05) assuming a rate of 60% at least 661 patients are needed in each of the 3 groups (PTL, PROM, and other).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Delivery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Preterm Labor

Group who goes into labor prior to 32 weeks of gestation

No interventions assigned to this group

Prelabor rupture of membranes

Group who have prelabor rupture of membranes are those who break their bag of water prior to 32 weeks gestation in the absence of labor.

No interventions assigned to this group

Premature birth before 32 weeks gestation

Premature birth before 32 weeks gestation not including PTL or PROM

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Delivery at participating hospitals at less than 32weeks of gestation based on best obstetrical dating
* Singleton pregnancy
* Delivery where the baby is:

1. Stillborn OR
2. Born alive and:
* expires before it leaves the delivery room OR
* is cared for in the Neonatal Intensive Care Unit or an Intermediate Care Nursery

Exclusion Criteria

* Patient less than 18 years of age
* Pregnancies that had previously been multiple gestations but where one or more fetuses had died after 12weeks of gestation
* Deliveries where the baby is born alive, does not expire in the delivery room but the baby does not get admitted to the NICU.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Obstetrix Medical Group

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Garite, MD

Role: PRINCIPAL_INVESTIGATOR

Obstetrix Medical Group

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Banner Desert Medical Center

Mesa, Arizona, United States

Site Status

Banner Good Samaritan Medical Center

Phoenix, Arizona, United States

Site Status

Scottsdale Healthcare-Shea Medical Center

Scottsdale, Arizona, United States

Site Status

Saddleback Memorial Medical Center

Laguna Hills, California, United States

Site Status

Good Samaritan Hospital

San Jose, California, United States

Site Status

Presbyterian/St Luke's Hospital

Denver, Colorado, United States

Site Status

Saint Luke's Hospital, Kansas City

Kansas City, Missouri, United States

Site Status

Mercy Hospital of St. Louis

St Louis, Missouri, United States

Site Status

Harris Methodist Hospital - Fort Worth

Fort Worth, Texas, United States

Site Status

Swedish Medical Center

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OBX0022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.